Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|October 15, 2016
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemiaLuciana De Luca, Giovanni D'Arena, Vittorio Simeon, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 21, 2016
MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short reportAntonella Caivano, Francesco La Rocca, Vittorio Simeon, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2025
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN StudyAlfredo Caturano, Raffaele Galiero, Vittorio Simeon, et al.
Andrology|January 10, 2026
Association Between Isolated Postprandial Dyslipidemia And Erectile DysfunctionCeleste Manfredi, Giampiero Della Rosa, Simone Tammaro, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 22, 2015
Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemiaStefania Trino, Luciana De Luca, Vittorio Simeon, et al.
Leukemia & Lymphoma|April 4, 2017
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patientsGiovanni D'Arena, Vittorio Simeon, Luca Laurenti, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 20, 2017
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cellsFrancesco La Rocca, Irma Airoldi, Emma Di Carlo, et al.
Oncotarget|June 6, 2015
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patternsIngrid Cifola, Marta Lionetti, Eva Pinatel, et al.
Stem Cell Research & Therapy|April 19, 2015
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party studyPellegrino Musto, Vittorio Simeon, Alberto Grossi, et al.
The Pharmacogenomics Journal|December 6, 2019
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)Amelia Filippelli, Simona Signoriello, Ciro Bancone, et al.
Pageof 15